TIPE2 mediates the suppressive effects of shikonin on MMP13 in osteosarcoma cells

Cellular Physiology and Biochemistry

Volumn 37, Issue 6, 2015, Pages 2434-2443

  Deng, Biyong ^a   Feng, Youwei ^a   Deng, Bixiang ^a  

^a Guiyang Medical College Hospital   (China)

Author keywords

Matrix metalloproteinase (MMP) 13; Osteosarcoma (OS); Shikonin; TIPE2

Indexed keywords

COLLAGENASE 3; REGULATOR PROTEIN; SHIKONIN; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 LIKE 2; UNCLASSIFIED DRUG; NAPHTHOQUINONE; SIGNAL PEPTIDE; TIPE2 PROTEIN, HUMAN;

ARTICLE; CANCER INCIDENCE; CELL INVASION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOSARCOMA CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN INTERACTION; PROTEIN SECRETION; REGULATORY MECHANISM; TRANSGENE; UPREGULATION; ADOLESCENT; CHILD; ENZYMOLOGY; FEMALE; METABOLISM; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADOLESCENT; CELL LINE, TUMOR; CHILD; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 13; NAPHTHOQUINONES; OSTEOSARCOMA;

EID: 84949604882     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000438596     Document Type: Article

References (48)

1. Tsuchiya H, Tomita K, Mori Y, Asada N, Morinaga T, Kitano S, Yamamoto N. Caffeine-Assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Anticancer Res 1998; 18: 657-666
2. Yang J, Zhang W. New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 2013; 25: 398-406
3. Li G, Fu D, Liang W, Fan L, Chen K, Shan L, Hu S, Ma X, Zhou K, Cheng B. Cyc1 silencing sensitizes osteosarcoma cells to trail-induced apoptosis. Cell Physiol Biochem 2014; 34: 2070-2080
4. Liu Y, He J, Chen X, Li J, Shen M, Yu W, Yang Y, Xiao Z. The proapoptotic effect of formononetin in human osteosarcoma cells: Involvement of inactivation of erk and akt pathways. Cell Physiol Biochem 2014; 34: 637-645
5. Wang Q, Cai J, Wang J, Xiong C, Zhao J. Mir-143 inhibits egfr-signaling-dependent osteosarcoma invasion. Tumour Biol 2014; 35: 12743-12748
6. Xiao Q, Zhang X, Wu Y, Yang Y. Inhibition of macrophage polarization prohibits growth of human osteosarcoma. Tumour Biol 2014; 35: 7611-7616
7. Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M, Quan ZX, Chen J. Microrna-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of sox4. Cell Physiol Biochem 2014; 34: 2180-2188
8. Li F, Li S, Cheng T. Tgf-beta1 promotes osteosarcoma cell migration and invasion through the mir-143-versican pathway. Cell Physiol Biochem 2014; 34: 2169-2179
9. He Y, Meng C, Shao Z, Wang H, Yang S. Mir-23a functions as a tumor suppressor in osteosarcoma. Cell Physiol Biochem 2014; 34: 1485-1496
10. Chen J, Fu H, Wang Z, Yin F, Li J, Hua Y, Cai Z A new synthetic ursolic acid derivative iua with anti-Tumor efficacy against osteosarcoma cells via inhibition of jnk signaling pathway. Cell Physiol Biochem 2014; 34: 724-733
11. Xu H, Liu X, Zhao J. Down-regulation of mir-3928 promoted osteosarcoma growth. Cell Physiol Biochem 2014; 33: 1547-1556
12. Xu G, Wang J, Jia Y, Shen F, Han W, Kang Y. Mir-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting hmga1. Cell Physiol Biochem 2014; 33: 1329-1339
13. Pan W, Wang H, Jianwei R, Ye Z. Microrna-27a promotes proliferation, migration and invasion by targeting map2k4 in human osteosarcoma cells. Cell Physiol Biochem 2014; 33: 402-412
14. Chen X, Luther G, Zhang W, Nan G, Wagner ER, Liao Z, Wu N, Zhang H, Wang N, Wen S, He Y, Deng F, Zhang J, Wu D, Zhang B, Haydon RC, Zhou L, Luu HH, He TC. The e-f hand calcium-binding protein s100a4 regulates the proliferation, survival and differentiation potential of human osteosarcoma cells. Cell Physiol Biochem 2013; 32: 1083-1096
15. Chang YW, Zhao YF, Cao YL, Gu XF, Li ZQ, Wang SQ, Miao JH, Zhan HS. Liver x receptor alpha inhibits osteosarcoma cell proliferation through up-regulation of foxo1. Cell Physiol Biochem 2013; 32: 180-186
16. Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 2004; 70: 217-228
17. Ryu B, Li Y, Qian ZJ, Kim MM, Kim SK. Differentiation of human osteosarcoma cells by isolated phlorotannins is subtly linked to cox-2, inos, mmps, and mapk signaling: Implication for chronic articular disease. Chem Biol Interact 2009; 179: 192-201
18. Zhou Y, Hu Z, Li N, Jiang R. Interleukin-32 stimulates osteosarcoma cell invasion and motility via akt pathway-mediated mmp-13 expression. Int J Mol Med 2015; 35: 1729-1733
19. Shang HS, Chang JB, Lin JH, Lin JP, Hsu SC, Liu CM, Liu JY, Wu PP, Lu HF, Au MK, Chung JG. Deguelin inhibits the migration and invasion of u-2 os human osteosarcoma cells via the inhibition of matrix metalloproteinase-2/-9 in vitro. Molecules 2014; 19: 16588-16608
20. Osaki M, Takeshita F, Sugimoto Y, Kosaka N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T, Ito H, Oshimura M, Ochiya T. Microrna-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther 2011; 19: 1123-1130
21. Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, Oneyama C, Okada M, Takumi T, Nishita M, Minami Y. Autonomous regulation of osteosarcoma cell invasiveness by wnt5a/ror2 signaling. Oncogene 2009; 28: 3197-3208
22. Ma O, Cai WW, Zender L, Dayaram T, Shen J, Herron AJ, Lowe SW, Man TK, Lau CC, Donehower LA. Mmp13, birc2 (ciap1), and birc3 (ciap2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. Cancer Res 2009; 69: 2559-2567
23. Andujar I, Rios JL, Giner RM, Recio MC. Pharmacological properties of shikonin-A review of literature since 2002. Planta medica 2013; 79: 1685-1697
24. Andujar I, Recio MC, Giner RM, Rios JL. Traditional chinese medicine remedy to jury: The pharmacological basis for the use of shikonin as an anticancer therapy. Curr Med Chem 2013; 20: 2892-2898
25. Wang R, Yin R, Zhou W, Xu D, Li S. Shikonin and its derivatives: A patent review. Expert Opin Ther Pat 2012; 22: 977-997
26. Fu Z, Deng B, Liao Y, Shan L, Yin F, Wang Z, Zeng H, Zuo D, Hua Y, Cai Z. The anti-Tumor effect of shikonin on osteosarcoma by inducing rip1 and rip3 dependent necroptosis. BMC Cancer 2013; 13: 580
27. Deng B, Qiu B. Shikonin inhibits invasiveness of osteosarcoma through mmp13 suppression. Tumour Biol 2015 in press. DOI: 10.1007/s13277-015-3662-1
28. Zhang X, Wang J, Fan C, Li H, Sun H, Gong S, Chen YH, Shi Y. Crystal structure of tipe2 provides insights into immune homeostasis. Nat Struct Mol Biol 2009; 16: 89-90
29. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, Kong L, Xu L, Hilliard B, Hu S, Shen H, Yang X, Chen YH. Tipe2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 2008; 133: 415-426
30. Lou Y, Zhang G, Geng M, Zhang W, Cui J, Liu S. Tipe2 negatively regulates inflammation by switching arginine metabolism from nitric oxide synthase to arginase. PLoS One 2014; 9: e96508
31. Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, Song Z, El-Gohary Y, Prasadan K, Shiota C, Gittes GK. M2 macrophages promote beta-cell proliferation by up-regulation of smad7. Proc Natl Acad Sci U S A 2014; 111: E1211-1220
32. Song X, Xie S, Lu K, Wang C. Mesenchymal stem cells alleviate experimental asthma by inducing polarization of alveolar macrophages. Inflammation 2015; 38: 485-492
33. Wang B, Miao Y, Zhao Z, Zhong Y. Inflammatory macrophages promotes development of diabetic encephalopathy. Cell Physiol Biochem 2015; 36: 1142-1150
34. Pan B, Liu G, Jiang Z, Zheng D. Regulation of renal fibrosis by macrophage polarization. Cell Physiol Biochem 2015; 35: 1062-1069
35. Liu W, Zhang S, Gu S, Sang L, Dai C. Mesenchymal stem cells recruit macrophages to alleviate experimental colitis through tgfbeta1. Cell Physiol Biochem 2015; 35: 858-865
36. Lin S, Qiu M, Chen J. Il-4 modulates macrophage polarization in ankylosing spondylitis. Cell Physiol Biochem 2015; 35: 2213-2222
37. Li D, Song L, Fan Y, Li X, Li Y, Chen J, Zhu F, Guo C, Shi Y, Zhang L. Down-regulation of tipe2 mrna expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol 2009; 133: 422-427
38. Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y, Qu Z, Cui J, Zhang G, Liang X, Ma C, Gao C, Chen Y, Liu S. Roles of tipe2 in hepatitis b virus-induced hepatic inflammation in humans and mice. Mol Immunol 2011; 48: 1203-1208
39. Zhang Y, Wei X, Liu L, Liu S, Wang Z, Zhang B, Fan B, Yang F, Huang S, Jiang F, Chen YH, Yi F. Tipe2, a novel regulator of immunity, protects against experimental stroke. J Biol Chem 2012; 287: 32546-32555
40. Kong L, Liu K, Zhang YZ, Jin M, Wu BR, Wang WZ, Li W, Nan YM, Chen YH. Downregulation of tipe2 mrna expression in peripheral blood mononuclear cells from patients with chronic hepatitis c. Hepatol Int 2013; 7: 844-849
41. Ma Y, Liu X, Wei Z, Wang X, Wang Z, Zhong W, Li Y, Zhu F, Guo C, Zhang L, Wang X. The expression and significance of tipe2 in peripheral blood mononuclear cells from asthmatic children. Scand J Immunol 2013; 78: 523-528
42. Li Y, Li X, Liu G, Sun R, Wang L, Wang J, Wang H. Downregulated tipe2 is associated with poor prognosis and promotes cell proliferation in non-small cell lung cancer. Biochem Biophys Res Commun 2015; 457: 43-49
43. Cao X, Zhang L, Shi Y, Sun Y, Dai S, Guo C, Zhu F, Wang Q, Wang J, Wang X, Chen YH, Zhang L. Human tumor necrosis factor (tnf)-Alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting rac1. Mol Cancer 2013; 12: 149
44. Gus-Brautbar Y, Johnson D, Zhang L, Sun H, Wang P, Zhang S, Zhang L, Chen YH. The anti-inflammatory tipe2 is an inhibitor of the oncogenic ras. Mol Cell 2012; 45: 610-618
45. Zhang Z, Qi H, Hou S, Jin X. Tipe2 mrna overexpression correlates with tnm staging in renal cell carcinoma tissues. Oncol Lett 2013; 6: 571-575
46. Ponten J, Saksela E. Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer 1967; 2: 434-447
47. Fogh J, Wright WC, Loveless JD. Absence of hela cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 1977; 58: 209-214
48. Zhang YH, Yan HQ, Wang F, Wang YY, Jiang YN, Wang YN, Gao FG. Tipe2 inhibits tnf-Alpha-induced hepatocellular carcinoma cell metastasis via erk1/2 downregulation and nf-kappab activation. Int J Oncol 2015; 46: 254-264